Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) has provided an update.
Shanghai Junshi Biosciences announced the latest progress of a previously disclosed plan by chairman and controlling shareholder Xiong Jun to increase his holdings in the company’s A and H shares by at least RMB100 million over a 12‑month period starting 12 April 2025. The plan allocates no less than RMB50 million to A shares and will be executed via permitted methods on the Shanghai and Hong Kong exchanges, signaling management’s confidence in the company’s long‑term prospects and alignment with minority shareholders.
As of the announcement date, Xiong Jun has acquired 365,382 A shares through centralized bidding on the Shanghai Stock Exchange, representing about 0.04% of the company’s total share capital and involving a total transaction value of approximately RMB12.21 million. The shareholding increase plan remains incomplete, and the chairman intends to continue raising his stake in line with the plan as market opportunities arise, which could support market sentiment toward the stock and reinforce the company’s governance stability.
The most recent analyst rating on (HK:1877) stock is a Hold with a HK$22.50 price target. To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock, see the HK:1877 Stock Forecast page.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a China-based biopharmaceutical company listed in both Shanghai and Hong Kong, engaged in the research, development and commercialization of innovative medicines. The company operates through A shares on the Shanghai Stock Exchange and H shares on the Hong Kong Stock Exchange, reflecting a focus on both domestic and international capital markets.
Average Trading Volume: 3,093,630
Technical Sentiment Signal: Sell
Current Market Cap: HK$32.13B
For detailed information about 1877 stock, go to TipRanks’ Stock Analysis page.